Dr. Kurt Mu-I Hong, MD

Dr. Hong practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Hong's NPI, 1225056831, was assigned on July 18, 2006. Dr. Hong graduated from Harvard Medical School in 1999. Dr. Hong's California license number on file is A72848.

Dr. Hong's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Hong's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Hong is also affiliated with USC Verdugo Hills Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Hong to 1 more group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hong practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Hong's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Hong is board certified in internal medicine by the American Board of Internal Medicine. Dr. Hong has a license on file in California.

Dmand AI lists anxiety, asthma, bronchitis, chronic diabetes, chronic hypertension, diabetic emergency, fatty liver and high cholesterol among the conditions Dr. Hong treats.

CMS data shows 470 Medicare services from Dr. Hong across 5 procedure codes in 2024, for 360 Medicare patients. Medicare paid $37,023 for them.

CMS counts 360 Medicare patients who saw Dr. Hong in 2024. The largest group is 65 to 74, with 152 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hong's median patient age at 55, with 75% women.

In 2024, Dr. Hong wrote 1,350 Medicare Part D claims for 191 patients. 62% of them were for generic drugs. CMS names the drug for 1,063 of them, across 22 drugs with 11 or more claims each, at $494,984 in total drug cost. In 2023, CMS named 1,194 claims across 19 drugs.

Dr. Hong accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hong as offering telehealth.

Dmand AI links 2 papers to Dr. Hong in 2013. Dr. Hong's most frequent co-authors are Steve Ching-Tsung Chen, MD, David Heber, MD and Zhaoping Li, MD.

Dmand AI links Dr. Hong to 1 clinical trial. Conditions studied include Malnutrition and Nutrition Disorders.

CMS Open Payments shows 107 general payments to Dr. Hong from 6 drug and device companies from 2016 to 2023. Honoraria make up the largest share, 74% of the total. Orexigen Therapeutics, Inc. paid the most, $92,522.

Dmand AI lists 1 award for Dr. Hong, most recently CMS Stage 1 EHR in 2012.

Dr. Hong graduated from Harvard Medical School in 1999.

Dr. Hong is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.